Evolus (EOLS) Asset Utilization Ratio (2019 - 2026)
Evolus (EOLS) posted Asset Utilization Ratio of 1.35 for Q1 2026, up 1.18% on a QoQ basis from 1.34 in Q4 2025, and up 9.41% year-over-year from 1.24 in Q1 2025.
Evolus (EOLS) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Evolus' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 1.35 for Q1 2026.
- Quarterly Asset Utilization Ratio rose 9.41% year-over-year to 1.35 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.35 (up 9.41% YoY) and the FY2025 annual result came in at 1.3, up 2.63% from the prior year.
- Asset Utilization Ratio was 1.35 for Q1 2026 at Evolus, up from 1.34 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.35 in Q1 2026 and bottomed at 0.51 in Q1 2022.
- A 5-year average of 1.03 and a median of 1.07 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 90.13% — and 2024, when it decreased 2.25%.
- Evolus' Asset Utilization Ratio stood at 0.8 in 2022, then soared by 41.21% to 1.13 in 2023, then advanced by 1.77% to 1.15 in 2024, then advanced by 15.95% to 1.34 in 2025, then rose by 1.18% to 1.35 in 2026.
- Business Quant data shows EOLS's Asset Utilization Ratio at 1.35 in Q1 2026, 1.34 in Q4 2025, and 1.28 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 1.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 |
| Dec 31, 2025 | 1.34 |
| Sep 30, 2025 | 1.28 |
| Jun 30, 2025 | 1.26 |
| Mar 31, 2025 | 1.24 |
| Dec 31, 2024 | 1.15 |
| Sep 30, 2024 | 1.07 |
| Jun 30, 2024 | 1.03 |
| Mar 31, 2024 | 1.06 |
| Dec 31, 2023 | 1.13 |
| Sep 30, 2023 | 1.10 |
| Jun 30, 2023 | 1.02 |
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.80 |
| Sep 30, 2022 | 0.69 |
| Jun 30, 2022 | 0.61 |
| Mar 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.38 |
| Jun 30, 2021 | 0.39 |